201 related articles for article (PubMed ID: 32889753)
21. Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia.
Le Bousse-Kerdilès MC; Chevillard S; Charpentier A; Romquin N; Clay D; Smadja-Joffe F; Praloran V; Dupriez B; Demory JL; Jasmin C; Martyré MC
Blood; 1996 Dec; 88(12):4534-46. PubMed ID: 8977245
[TBL] [Abstract][Full Text] [Related]
22. Platelet-derived growth factor receptor β (PDGFRβ) immunohistochemistry highlights activated bone marrow stroma and is potentially predictive for fibrosis progression in prefibrotic myeloproliferative neoplasia.
Méhes G; Tzankov A; Hebeda K; Anagnostopoulos I; Krenács L; Bedekovics J
Histopathology; 2015 Nov; 67(5):617-24. PubMed ID: 25825163
[TBL] [Abstract][Full Text] [Related]
23. GATA1 downregulation in prefibrotic and fibrotic stages of primary myelofibrosis and in the myelofibrotic progression of other myeloproliferative neoplasms.
Sangiorgio VFI; Nam A; Chen Z; Orazi A; Tam W
Leuk Res; 2021 Jan; 100():106495. PubMed ID: 33360878
[TBL] [Abstract][Full Text] [Related]
24. Focus on Osteosclerotic Progression in Primary Myelofibrosis.
Spampinato M; Giallongo C; Romano A; Longhitano L; La Spina E; Avola R; Scandura G; Dulcamare I; Bramanti V; Di Rosa M; Vicario N; Parenti R; Li Volti G; Tibullo D; Palumbo GA
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33477816
[TBL] [Abstract][Full Text] [Related]
25. Splenic marginal zone lymphoma presenting as myelofibrosis associated with bone marrow involvement of lymphoma cells which secrete a large amount of TGF-beta.
Matsunaga T; Takemoto N; Miyajima N; Okuda T; Nagashima H; Sato T; Terui T; Sasaki H; Ohmi N; Hirayama Y; Tamura Y; Niitsu Y
Ann Hematol; 2004 May; 83(5):322-5. PubMed ID: 15060752
[TBL] [Abstract][Full Text] [Related]
26. Peripheral T-cell lymphoma together with myelofibrosis with elevated plasma transforming growth factor-beta1.
Okabe S; Miyazawa K; Iguchi T; Sumi M; Takaku T; Ito Y; Kimura Y; Serizawa H; Mukai K; Ohyashiki K
Leuk Lymphoma; 2005 Apr; 46(4):599-602. PubMed ID: 16019489
[TBL] [Abstract][Full Text] [Related]
27. PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis.
Augello C; Gianelli U; Falcone R; Tabano S; Savi F; Bonaparte E; Ciboddo M; Paganini L; Parafioriti A; Ricca D; Lonati S; Cattaneo D; Fracchiolla NS; Iurlo A; Cortelezzi A; Bosari S; Miozzo M; Sirchia SM
Leuk Res; 2015 Feb; 39(2):236-41. PubMed ID: 25498506
[TBL] [Abstract][Full Text] [Related]
28. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts.
Mori Y; Hatamochi A; Arakawa M; Ueki H
Arch Dermatol Res; 1998 Mar; 290(3):158-62. PubMed ID: 9558492
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-beta overexpression in cutaneous extramedullary hematopoiesis of a patient with myelodysplastic syndrome associated with myelofibrosis.
Kawakami T; Kimura S; Kato M; Mizoguchi M; Soma Y
J Am Acad Dermatol; 2008 Apr; 58(4):703-6. PubMed ID: 18342720
[TBL] [Abstract][Full Text] [Related]
30. Functional similarity between TGF-beta type 2 and type 1 receptors in the female reproductive tract.
Ni N; Fang X; Li Q
Sci Rep; 2021 Apr; 11(1):9294. PubMed ID: 33927274
[TBL] [Abstract][Full Text] [Related]
31. Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis.
Decker M; Martinez-Morentin L; Wang G; Lee Y; Liu Q; Leslie J; Ding L
Nat Cell Biol; 2017 Jun; 19(6):677-688. PubMed ID: 28481328
[TBL] [Abstract][Full Text] [Related]
32. The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.
Uchiyama T; Kawabata H; Miura Y; Yoshioka S; Iwasa M; Yao H; Sakamoto S; Fujimoto M; Haga H; Kadowaki N; Maekawa T; Takaori-Kondo A
Cancer Med; 2015 Oct; 4(10):1558-72. PubMed ID: 26276681
[TBL] [Abstract][Full Text] [Related]
33. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression.
Komura E; Tonetti C; Penard-Lacronique V; Chagraoui H; Lacout C; Lecouédic JP; Rameau P; Debili N; Vainchenker W; Giraudier S
Cancer Res; 2005 Apr; 65(8):3281-9. PubMed ID: 15833861
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes.
Castro-Malaspina H; Moore MA
Nouv Rev Fr Hematol (1978); 1982; 24(4):221-6. PubMed ID: 6292827
[TBL] [Abstract][Full Text] [Related]
35. LncRNA PCAT6 promotes tumor progression in osteosarcoma via activation of TGF-β pathway by sponging miR-185-5p.
Zhu C; Huang L; Xu F; Li P; Li P; Hu F
Biochem Biophys Res Commun; 2020 Jan; 521(2):463-470. PubMed ID: 31676070
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of ALK5 inhibition in myelofibrosis.
Yue L; Bartenstein M; Zhao W; Ho WT; Han Y; Murdun C; Mailloux AW; Zhang L; Wang X; Budhathoki A; Pradhan K; Rapaport F; Wang H; Shao Z; Ren X; Steidl U; Levine RL; Zhao ZJ; Verma A; Epling-Burnette PK
JCI Insight; 2017 Apr; 2(7):e90932. PubMed ID: 28405618
[TBL] [Abstract][Full Text] [Related]
37. TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling.
Nyati S; Gregg BS; Xu J; Young G; Kimmel L; Nyati MK; Ray D; Speers C; Rehemtulla A
Neoplasia; 2020 Apr; 22(4):163-178. PubMed ID: 32143140
[TBL] [Abstract][Full Text] [Related]
38. Canonical Wnt/β-Catenin Signaling Pathway Is Dysregulated in Patients With Primary and Secondary Myelofibrosis.
Lucijanic M; Livun A; Tomasovic-Loncaric C; Stoos-Veic T; Pejsa V; Jaksic O; Prka Z; Kusec R
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):523-526. PubMed ID: 27381374
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
[TBL] [Abstract][Full Text] [Related]
40. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
Martyré MC; Magdelenat H; Bryckaert MC; Laine-Bidron C; Calvo F
Br J Haematol; 1991 Jan; 77(1):80-6. PubMed ID: 1998600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
